Designed to target skin cancer, the implantable vaccine opens a door to treating many cancers and inflammatory diseases
A cross-disciplinary team of scientists, engineers, and clinicians announced today that they have begun a Phase I clinical trial of an implantable vaccine to treat melanoma, the most lethal form of skin cancer.
The effort is the fruit of a new model of translational research being pursued at the Wyss Institute for Biologically Inspired Engineering at Harvard University that integrates the latest cancer research with bioinspired technology development. It was led by Wyss Core Faculty member David J. Mooney, Ph.D., who is also the Robert P. Pinkas Family Professor of Bioengineering at the Harvard School of Engineering and Applied Sciences (SEAS), and Wyss Institute Associate Faculty member Glenn Dranoff, M.D., who is co-leader of Dana-Farber Cancer Institute’s Cancer Vaccine Center.
Most therapeutic cancer vaccines available today require doctors to first remove the patient’s immune cells from the body, then reprogram them and reintroduce them back into the body. The new approach, which was first reported to eliminate tumors in mice in Science Translational Medicine in 2009, the year the Wyss Institute was launched, instead uses a small disk-like sponge about the size of a fingernail that is made from FDA-approved polymers. The sponge is implanted under the skin, and is designed to recruit and reprogram a patient’s own immune cells “on site,” instructing them to travel through the body, home in on cancer cells, then kill them.
The technology was initially designed to target cancerous melanoma in skin, but might have application to other cancers. In the preclinical study reported in Science Translational Medicine, 50 percent of mice treated with two doses of the vaccine — mice that would have otherwise died from melanoma within about 25 days — showed complete tumor regression.
“Our vaccine was made possible by combining a wide range of biomedical expertise that thrives in Boston and Cambridge,” said Mooney, who specializes in the design of biomaterials for tissue engineering and drug delivery. “It reflects the bioinspired engineering savvy and technology development focus of engineers and scientists at the Wyss Institute and Harvard SEAS, as well as the immunological and clinical expertise of the researchers and clinicians at Dana-Farber and Harvard Medical School.”
“This is expected to be the first of many new innovative therapies made possible by the Wyss Institute’s collaborative model of translational research that will enter human clinical trials,” said Wyss Founding Director Don Ingber, M.D., Ph.D., who is also the Judah Folkman Professor of Vascular Biology at Harvard Medical School and Boston Children’s Hospital, and a Professor of Bioengineering at Harvard SEAS. “It validates our approach, which strives to move technologies into the clinical space much faster than would be possible in a traditional academic environment. It’s enormously gratifying to see one of our first technologies take this giant leap forward.”
The Wyss Institute comprises a consortium of researchers, engineers, clinicians, and staff with industrial and business development experience from the Wyss Institute and nine other collaborating institutions in Greater Boston.
“It is rare to get a new technology tested in the laboratory and moved into human clinical trials so quickly,” said Dranoff, who is also a Professor of Medicine at Harvard Medical School, and Leader of the Dana-Farber/Harvard Cancer Center Program in Cancer Immunology. “We’re beyond thrilled with the momentum, and excited about its potential.”
The Latest Bing News on:
- The American Cancer Society Campaign Aims to Increase HPV Vaccination During Pandemicon August 3, 2020 at 5:18 am
The American Cancer Society Campaign Aims to Increase HPV Vaccination During PandemicPR NewswireATLANTA,Coronavirus threatens to slow progress against cancer preventionATLANTA, Aug.
- AIVITA Biomedical Publishes Review of GM-CSF History and Rationale as Vaccine Adjuvant in Melanoma Managementon August 3, 2020 at 5:00 am
AIVITA Biomedical, Inc., a private biotechnology company developing personalized vaccines for the treatment of cancer and prevention ...
- And The COVID-19 Vaccine Winner Is: 'BioNTech SE'on August 3, 2020 at 4:30 am
The BioNTech/Pfizer team has launched its Phase 2/3 clinical trial in the USA and internationally for its COVID-19 vaccine on July 27, 2020, after excellent Phase 1/2 clinical trial results.
- Should you volunteer for a COVID-19 vaccine trial? Who qualifies, and what are the side effects?on August 3, 2020 at 2:05 am
Clinical trials of vaccines are being developed by several companies. Here’s who they’re looking for, and what’s involved.
- The color of COVID: Will vaccine trials reflect America’s diversity?on August 2, 2020 at 1:50 am
Though Black and Latino people are at greater risk for COVID-19 and its most severe effects, historically these groups have been less likely to be included in clinical trials for disease treatment.
- Who should get the Covid-19 vaccine first? It's way trickier than you might thinkon August 1, 2020 at 3:56 pm
Vaccinating nearly 8 billion people won't happen overnight. Bioethicists weigh in on the thorny issue of who should get the vaccine first -- and why.
- New Duke vaccine 'works beautifully' against breast canceron July 31, 2020 at 11:13 am
According to new research conducted at the Duke Cancer Institute, a vaccine developed at the university for breast cancer is part of part of a successful, "effective" two-drug strategy for fighting ...
- Touchlight, Cancer Research UK and University of Southampton team up to develop DNA cancer vaccineon July 31, 2020 at 5:50 am
Cancer Research UK, the University of Southampton and Touchlight Genetics, a London based biotechnology company, today (Wednesday) announce a new clinical development partnership to progress a ...
- Large U.S. COVID-19 vaccine trials will exclude pregnant women for nowon July 31, 2020 at 5:11 am
The first two COVID-19 vaccines to enter large-scale U.S. trials will not be tested in pregnant women this year, raising questions about how this vulnerable population will be protected from the ...
- Investigational breast cancer vaccine plus immune therapy work well in tandemon July 30, 2020 at 8:23 am
A vaccine for HER2-positive breast cancers that is being tested in a clinical trial at Duke Cancer Institute is part of an effective, two-drug strategy for enlisting the immune system to fight ...
The Latest Google Headlines on:
The Latest Bing News on:
Fix the internet
- The Political Fix: What will the August 5 Ram temple ceremony mean for the BJP – and India?on August 2, 2020 at 9:15 pm
Welcome to The Political Fix by Rohan Venkataramakrishnan, a newsletter on Indian politics and policy. To get it in your inbox every week, sign up here. We don’t charge for this newsletter, but if you ...
- The U.S. wastes $161B worth of food every year. A.I. is helping us fix thaton August 2, 2020 at 6:12 am
Up to 40% of food produced gets wasted in the United States every year. Could A.I. technology help bring about positive changes? These companies think so.
- Some OnePlus Nord owners report screen tinting issues (Update: Fix incoming)on July 31, 2020 at 8:53 am
The OnePlus Nord screen tinting issue described below will apparently get a fix soon. According to a statement from the company given to 9to5Google, a software fix is on the way. However, OnePlus ...
- Automakers Hype Hacking Threat To Sink Pro-Repair Measureon July 31, 2020 at 7:29 am
Cyberstalkers on the left, mechanics on the right: a ballot measure to expand access to wireless repair data in Massachusetts has automakers squaring off against right to repair advocates. But the ...
- Broadbanned: Still no affordable fix for a broadband internet connection just out of reachon July 26, 2020 at 5:06 am
The problem of people who can see the nearest broadband connection but can’t get it at any reasonable price remains one we not only haven’t solved.
- No signal? This new tech could fix the biggest frustration with your train journeyon July 24, 2020 at 7:38 am
It is hoped that new equipment housing small cells and wireless antennas can be attached to electrified overhead line equipment (OLE) installed over roughly a third of Britain's r ...
- Welcome to Guides & Gear: The Drive’s New Channel On How To Fix Everything And Make Smart Buyson July 23, 2020 at 8:23 am
Guides & Gear was born out of the desire to give The Drive’s readers the peace of mind in the garage. When they go to replace a battery, fuel filter, or temperature gauge, they’ll not only be able to ...
- Second stimulus check: Millions of Americans missed the first round. Here's how Congress could fix thaton July 22, 2020 at 4:45 pm
On Mondays, Wednesdays, and Fridays, volunteers in a community outside Seattle set up tables on the street and open their laptops to help homeless people sign up for economic stimulus payments.
- Millions of Americans missed the first stimulus check. Here’s how Congress could fix the next oneon July 22, 2020 at 3:04 pm
Still, it’s likely people will need access to the internet, which proved to be a hurdle for many low-income people, especially during a pandemic when tax assistance offices closed along with ...
- How to Fix Windows 10's Latest 'No Internet Connection' Bugon July 21, 2020 at 2:09 pm
Windows 10 updates tend to break things, and the most recent Window 10 version 2004 update is no exception. According to numerous forum posts, the latest irksome bug prevents Windows 10 apps from ...